At the Keystone Symposium in Cape Town, the Global HIV Vaccine Enterprise announced the appointment of its first executive director and the opening of a new secretariat in New York City. Dr. Alan Bernstein, founding president of the Canadian Institutes of Health Research, will lead the international alliance of researchers, funders and advocates dedicated to speeding the search for an HIV vaccine.
October 15, 2007, marks the fifth annual National Latino AIDS Awareness Day. On this day, the National Institute of Allergy and Infectious Diseases (NIAID) pledges to continue working toward reducing the burden of HIV/AIDS in the Latino community in the United States.
New drugs for multi-drug resistant (MDR) tuberculosis that are expected to shorten the duration of treatment will be available in four to five years time, an expert has said.
There has been an alarming rise in the number of HIV patients in Bhutan, with the Health Ministry detecting about 20 cases this year.
The Stop TB Partnership’s Global Drug Facility and UNITAID announced a collaboration with 19 countries to address life-threatening shortages of anti-tuberculosis drugs.
A combination of drugs widely used to treat infections caused by HIV appears to stop brain damage caused by the virus as well, according to a study published in the Oct. 9, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
A post-campaign survey of AIDS Healthcare Foundation’s (AHF) innovative “Stay Negative” social marketing campaign recently revealed the initiative’s success at breaking through to its target audience and reaching its objective to create an effective health education and risk reduction campaign to raise awareness among gay males in Los Angeles County that HIV infection is still a serious threat.
An interdisciplinary team of biomedical researchers from the USC Viterbi School, the College and the Keck School of Medicine of USC has received a $6-million Bioengineering Research Partnership grant from the National Institutes of Health (NIH) to begin designing visual aids for millions of older adults who suffer from significant vision loss.
Researchers at the Agency for Science, Technology and Research’s (A*STAR) Institute of Molecular and Cell Biology (IMCB) have discovered new molecular mechanisms that provide a more detailed understanding of how the normally benign Dr. Jekyll-like fungus known as Candida albicans transforms into a serious and often life-threatening Mr. Hyde-like form.
Although there has been a decrease in the prevalence of HIV, the Department of Health is intensifying its HIV prevention programme including the improvement of regimen for Prevention of Mother-To-Child Transmission of HIV (PMTCT), said Health Minister, Dr Manto Tshabalala-Msimang.